Dr. Rodney Anton Samaan, MD

Dr. Samaan practices at Mission Community Hospital in Panorama City, California, part of Mission Community Hospital.

Dr. Samaan's NPI, 1578776720, was assigned on May 7, 2007. Dr. Samaan graduated from University Of Kentucky College Of Medicine in 2003. Dr. Samaan holds California license A119309.

Dr. Samaan's primary practice is Mission Community Hospital, at 14850 Roscoe Blvd, Panorama City, CA 91402 in Los Angeles County. The practice phone is (818) 904-3100.

Dr. Samaan's primary practice is Mission Community Hospital in Panorama City, California, part of Mission Community Hospital. Dr. Samaan is also affiliated with Panorama City Medical Center. Dmand AI also links Dr. Samaan to 1 more hospital, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samaan practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Samaan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Samaan is board certified in echocardiography by the American Society of Echocardiography. Dmand AI has Dr. Samaan's licenses on file in 6 states: California, Kentucky, Hawaii, New York, Indiana and Ohio.

Dmand AI lists aneurysm, atrial fibrillation and flutter, chronic hypertension, heart failure, high cholesterol, hypertension, intermittent racing heartbeat (PSVT) and obesity among the conditions Dr. Samaan treats.

CMS data shows 1,729 Medicare services from Dr. Samaan across 7 procedure codes in 2024, for 365 Medicare patients. Medicare paid $147,658 for them.

CMS counts 365 Medicare patients who saw Dr. Samaan in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 3.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samaan's median patient age at 68, with 45% women.

In 2024, Dr. Samaan wrote 2,802 Medicare Part D claims for 157 patients. 71% of them were for generic drugs. CMS names the drug for 2,376 of them, across 52 drugs with 11 or more claims each, at $644,237 in total drug cost. In 2023, CMS named 2,011 claims across 52 drugs.

Dr. Samaan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Samaan as offering telehealth.

Dmand AI links 2 papers to Dr. Samaan. Dr. Samaan's most frequent co-authors are Nidal Isber, MD and Hezekiah Oluwarotimi Sobamowo, MD.

Dmand AI links Dr. Samaan to 11 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Heart Failure, Heart Diseases and Hypertension. Alnylam Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Samaan that name 2 trials.

CMS Open Payments shows 458 general payments to Dr. Samaan from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Novo Nordisk Inc paid the most, $77,631. It also lists 19 research payments totaling $191,533 from 2022 to 2024, naming 2 clinical trials.

Dmand AI lists 9 awards for Dr. Samaan, most recently CMS Stage 1 EHR in 2013.

Dr. Samaan graduated from University Of Kentucky College Of Medicine in 2003.

Dr. Samaan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.